CGON

CG Oncology, Inc. Common stockNASDAQHealthcare

$67.48+1.03%ClosedMarket Cap: $5.70B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-02-27	HC Wainwright & Co.	—	Buy	—
2026-02-10	Truist Securities	—	Buy	—
2026-01-21	RBC Capital	—	Outperform	—
2026-01-16	Piper Sandler	—	Overweight	—
2025-11-17	RBC Capital	—	Outperform	—
2025-09-26	JP Morgan	—	Overweight	—
2025-09-17	Morgan Stanley	—	Overweight	—
2025-09-15	HC Wainwright & Co.	—	Buy	—
2025-09-08	Cantor Fitzgerald	—	Overweight	—
2025-07-16	RBC Capital	—	Outperform	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$-2.01	$140.6M	10
Sun Dec 31	$0.46	$482.3M	10
Mon Dec 31	$3.22	$908.0M	4
Tue Dec 31	$6.52	$1.43B	4